Drug Trial Radar · NCT06830850
A Trial of HRS-5041-103 to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of HRS-5041 in Subjects With Metastatic Castration-resistant Prostate Cancer
Last checked: Nov 20, 2026Latest source record: Oct 14, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
25
Planned (sponsor's estimate)
Start
Jun 15, 2025
Primary completion
Dec 30, 2026
Study completion Mar 15, 2027
Sponsor
- Lead sponsor
- Atridia Pty Ltd.Industry
- Sponsor type
- Industry
- First posted
- Feb 17, 2025
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- Male only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of 5041-103 in Subjects with Metastatic Castration-resistant Prostate Cancer.
Conditions
- Metastatic Castration Resistant Prostate Cancer
Interventions
HRS-5041 Single dose of HRS-5041 orally administeredDrug
HRS-5041 Oral dosage (Tablet) Oral dosage administration, 28 days per cycle.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence and severity of adverse events, ECOG PS score, vital signs (pulse rate, respiratory rate, blood pressure, body temperature), ECG, clinical chemistry, hematology, urinalysis and physical examinationTime frame: Screening up to study completion, an average of 1 year.
Locations
11 sites in 1 country. Site status is shown where the registry gives one.
Icon Cancer Centre South Brisbane
Brisbane, Australia
John Flynn Private Hospital
Brisbane, Australia
Eastern Health (Box Hill Hospital)
Melbourne, Australia
Linear Clinical Research Ltd
Perth, Australia
Macquarie University
Sydney, Australia
MUPharm Pty Limited trading as Macquarie University Hospital Pharmacy
Sydney, Australia
Illawarra Shoalhaven Local Health District (Wollongong Hospital)
Wollongong, Australia
GenesisCare North Shore (Oncology)
Sydney, New South Wales, Australia
Sydney Adventist Hospital
Sydney, New South Wales, Australia
Cancer Research SA
Adelaide, South Australia, Australia
Southern Oncology Clinical Research Unit
Adelaide, South Australia, Australia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.